Meta Healthcare was founded with the vision of becoming a preferred partner in the development and commercialisation of innovative metabolic medicines.
APR becomes our partner.
In Vitro experimentation - "A New Phe-Free Protein Substitute”
Pre-clinical trial: -“Kinetics: Absorption of AA with Physiomimic Technology™”
Sponsorship at SSIEM Rotterdam conference.
PKU GOLIKE Plus 3‐16 approved in the UK.
PKU GoLike Plus 3‐16 sampling program in the UK.
PKU GOLIKE Plus 3‐16 commercial launch in the UK.
Thinking about the future - PKU GOLIKE Plus 16+ expected commercial launch in the UK
Meta Healthcare LTD © 2021
Meta Healthcare Ltd informs that the following pages are reserved to Health Care Professional (HCP’s) and PKU patients and carers.
In no event, Meta Healthcare Ltd. and its affiliated companies shall be liable for any use or exploitation of the information contained in the following pages if not previously authorized in writing by Meta Healthcare Ltd.
By clicking on the following link you declare under your own responsibility to be an HCP, PKU patient or carer and to accept the conditions here above described.